About OrbiMed Advisors, LLC
OrbiMed is the world’s largest healthcare-dedicated investment firm, with close to USD5 billion in assets under management. Since inception of its private equity investment activities in 1993, OrbiMed has successfully invested in over 100 private companies across a wide range of therapeutic categories and stages of development. OrbiMed’s investment team includes approximately 30 experienced professionals with backgrounds in science, medicine, industry, finance and law. OrbiMed’s professionals work together using a collaborative, team-oriented approach to support our portfolio companies, which has earned OrbiMed a reputation as a capital provider of choice for life sciences companies of all stages.
OrbiMed has created Caduceus Asia Partners (CAP), the first pan-Asia life sciences-dedicated venture capital fund, with approximately USD180M under management. With offices in Shanghai and Mumbai, being an integral part of OrbiMed, the CAP team manages OrbiMed’s Asia-related investment activities. More information at: www.orbimed.com
